Skip to main content
search

Transform drug development for good

Solutions across all phases improve your insights, development pace, portfolio quality and submissions.

Contact us

How we’re changing the game

Certara empowers strategic leaders to focus on what matters most—delivering life-changing therapies to patients faster, better, and more safely. By unifying siloed drug development activities and standardizing data and insights across phases, Certara helps you make informed decisions across your portfolio. Through biosimulation, trial design, data analytics, and regulatory submissions, Certara optimizes your best bets for success. Together, we transform the journey from research to patient impact.

  1. 1 / 6
    Regulatory
    Streamline submissions with confidence
    Start with the end in mind. Build the body of scientific evidence global regulators require from the start of your development process with expert regulatory strategy, advice and support. Use the same tools the regulators do to explore, analyze and interpret data. Anticipate feedback and questions while ensuring your data is available for review in the required industry-standard formats. Simplify workflows, accelerate document creation, and ensure error-free regulatory requirements are met across the globe.
  2. 2 / 6
    Discovery
    Predict and select the right design faster for small molecules and biologics
    Start strong by mitigating risks and prioritizing the right compounds for development. Streamline your design-make-test-analyze cycle with our services for due diligence, competitive landscape analysis, target product profile (TPP) development, cheminformatics and biosimulation to make predictive, data-driven decisions that enhance efficiency and improve your chances of discovering breakthrough therapies.
  3. 3 / 6
    Preclinical
    Move your candidate to IND
    Progress your in vitro and early in vivo studies with the aid of biosimulation and proven drug development strategies. Build evidence and gain insight into your therapeutic window assessment and nonclinical plans (including CMC, toxicology, DMPK, clinical pharmacology, biomarker and regulatory strategies, First-in-Human design, and IND support). Explore dosing regimens, trial designs and drug interactions virtually before the trial commences. These crucial insights improve your chances of success.
  4. 4 / 6
    Early clinical
    Navigate to your first trial with model informed drug development
    We empower you to find the optimal path from the deluge of nonclinical, pharmacokinetic, pharmacodynamic, and clinical data to design the best strategy for trials and justify dosing with modeling and simulation. Interpret confounding data, target responding populations, maximize safety and efficacy tradeoffs, and predict the right dose. As your close partner, we streamline the journey from data to decisions, with the goal of informing comprehensive regulatory submissions.
  5. 5 / 6
    Late clinical
    Empower data accuracy and regulatory success
    Optimize pivotal trial designs to make the most of every enrolled patient. Use biosimulation to understand your therapy’s impact on different types of patient populations with virtual trials. Understand your data better with population modeling required to support comprehensive regulatory submissions. Achieve data standardization and prepare robust statistical analysis to support confident and compliant regulatory submissions. Leverage data to solidify your trial design and dosing strategy. Explore clinical trial outcomes, real world uptake scenarios and compare your therapy to others with AI-powered insight. Validate data for accuracy, and streamline decision-making across all trial phases for optimal results.
  6. 6 / 6
    Market access & commercial
    Maximize value with evidence-based market strategies
    Achieve your product’s full potential with effective pricing, reimbursement, and patient access strategies aligned to your target product profile. Leverage real-time, real-world insights to strengthen your market positioning, secure optimal coverage, and ensure broad accessibility across markets. Demonstrate your therapy’s value over the competition with confidence and achieve success in your reimbursement negotiations, patient care and superior outcomes.

Add immense value to your company and portfolio

Streamline drug development

Speed all phases of drug development, reducing silos, white spaces, redundancies – and cost – for faster, more efficient decision-making you can trust.

Make data-driven decisions

Make informed, data-backed decisions at every stage of development, reducing trial failures through scientific and data-based predictions that maximize return on investment.

Accelerate time to market

Leverage real-time insights from early-stage successes to inform later phases, saving years of development time while ensuring compliance and accuracy.

We can help you today

Years of consulting experience, and the trust in our solutions by international health authorities, are at your service. Contact us today.

The output of all our platforms are fully aligned with and favored by regulatory bodies.
We have collaborated on more than 8,000 customer projects in the last decade across a wide variety of therapeutic areas ranging from cancer and hematology to diabetes and hundreds of rare diseases.
Certara has helped clients win US$65 billion in venture capital and M&A deals since 2019.

Send an Inquiry